⌘K
Loading ticker…
As of 2026-08-24, Arcadia Biosciences, Inc. (RKDA) has a 3-month relative strength percentile of 7 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 27. The current market Stance is 47.8 (Neutral). Sector: Energy, ranked 1 of 11. Average daily range 13.1%, relative volume 1.18×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
RKDA is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -28.0% / -72.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
RKDA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $13K notional.
Held by 1 ETFs · $13K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $13K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RKDA Jan avg: -10.63% median: -11.21% win: 25% σ: 12.51% n: 4 2022-04-12 → 2026-07-31 | RKDA Feb avg: -2.10% median: -4.21% win: 25% σ: 15.90% n: 4 2022-04-12 → 2026-07-31 | RKDA Mar avg: -25.29% median: -24.69% win: 0% σ: 2.94% n: 4 2022-04-12 → 2026-07-31 | RKDA Apr avg: -11.13% median: -18.34% win: 20% σ: 17.58% n: 5 2022-04-12 → 2026-07-31 | RKDA May avg: 18.58% median: 34.57% win: 60% σ: 32.91% n: 5 2022-04-12 → 2026-07-31 | RKDA Jun avg: -15.54% median: -15.47% win: 20% σ: 13.42% n: 5 2022-04-12 → 2026-07-31 | RKDA Jul avg: -4.91% median: -7.97% win: 20% σ: 11.08% n: 5 2022-04-12 → 2026-07-31 | RKDA Aug avg: -3.34% median: -3.09% win: 50% σ: 14.16% n: 4 2022-04-12 → 2026-07-31 (current) | RKDA Sep avg: -16.49% median: -11.09% win: 0% σ: 15.69% n: 4 2022-04-12 → 2026-07-31 | RKDA Oct avg: 7.65% median: 4.92% win: 75% σ: 25.30% n: 4 2022-04-12 → 2026-07-31 | RKDA Nov avg: -16.77% median: -17.89% win: 0% σ: 10.01% n: 4 2022-04-12 → 2026-07-31 | RKDA Dec avg: 14.05% median: -5.57% win: 50% σ: 68.88% n: 4 2022-04-12 → 2026-07-31 |